SCHEMBL2954534

SCHEMBL2954534

CCCCCCCCCC(CCCCCCC)C(=O)NCC(C)O

nearest known ligand 0.53

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.46
GPR84 Q9NQS5 6/20 0.44
FFAR1 O14842 1/20 0.44
BIRC2 Q13490 1/20 0.43
LCK P06239 1/20 0.43
PPARD Q03181 1/20 0.43
ZDHHC20 Q5W0Z9 1/20 0.43
ZDHHC2 Q9UIJ5 1/20 0.43
EPHX1 P07099 1/20 0.42
SMPD1 P17405 1/20 0.42
CA1 P00915 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22304191 1.00 CA2 (0.46) CA2GPR84FFAR1BIRC2LCK
SCHEMBL2952253 1.00 CA2 (0.46) CA2GPR84FFAR1BIRC2LCK
SCHEMBL29205059 0.94 CA2 (0.41) CA2GPR84FFAR1BIRC2LCK
SCHEMBL29205057 0.94 CA2 (0.41) CA2GPR84FFAR1BIRC2LCK
SCHEMBL29205058 0.94 CA2 (0.41) CA2GPR84FFAR1BIRC2LCK
SCHEMBL23430580 0.87 EPHX1 (0.56) CA2GPR84BIRC2LCKPPARD
SCHEMBL6550164 0.85 HDAC7 (0.54) CA2CA1
SCHEMBL20535411 0.84 CA2 (0.47) CA2GPR84FFAR1BIRC2LCK
SCHEMBL2896967 0.83 MAPT (0.47) CA2GPR84FFAR1BIRC2
SCHEMBL29205062 0.83 GPR84 (0.42) GPR84FFAR1LCKPPARDZDHHC20

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3692123-A1 PASSENGER CAR LUBRICATING OIL COMPOSITIONS FOR FUEL ECONOMY Chevron Japan Ltd. (JP) 2020-08-12 EP disclosed
WO-2019069197-A1 PASSENGER CAR LUBRICATING OIL COMPOSITIONS FOR FUEL ECONOMY CHEVRON JAPAN LTD. (JP) 2019-04-11 WO disclosed
US-20190106651-A1 PASSENGER CAR LUBRICATING OIL COMPOSITIONS FOR FUEL ECONOMY CHEVRON JAPAN LTD. (JP) 2019-04-11 US disclosed
EP-2914704-B1 FRICTION MODIFIERS AND A METHOD OF MAKING THE SAME CHEVRON ORONITE CO (US) 2018-10-24 EP disclosed
US-9371499-B2 Friction modifiers and a method of making the same CHEVRON ORONITE COMPANY LLC (US) 2016-06-21 US disclosed
US-20150265506-A1 Foam-Promoting Compounds CRODA UNIQEMA, INC. 2015-09-24 US disclosed
EP-2914704-A1 FRICTION MODIFIERS AND A METHOD OF MAKING THE SAME Chevron Oronite Company LLC (US) 2015-09-09 EP disclosed
WO-2014070314-A1 FRICTION MODIFIERS AND A METHOD OF MAKING THE SAME CHEVRON ORONITE COMPANY LLC (US) 2014-05-08 WO disclosed
US-20140121141-A1 FRICTION MODIFIERS AND A METHOD OF MAKING THE SAME CHEVRON ORONITE COMPANY LLC (US) 2014-05-01 US disclosed
US-7754674-B2 Solvated non-ionic surfactants and fatty acids CRODA AMERICAS LLC (US) 2010-07-13 US disclosed
US-20100080767-A1 COMPOUNDS CRODA UNIQEMA, INC. (US) 2010-04-01 US disclosed
EP-2082022-A1 COMPOUNDS Croda Uniqema Inc (US) 2009-07-29 EP disclosed
EP-1643962-B1 SOLVATED NONIONIC SURFACTANTS AND FATTY ACIDS CRODA UNIQEMA INC (US) 2009-05-13 EP disclosed
US-20090105106-A1 Solvated non-ionic surfactants and fatty acids CRODA UNIQUEMA, INC. (US) 2009-04-23 US disclosed
US-7479473-B2 Solvated nonionic surfactants and fatty acids CRODA UNIQEMA, INC. (US) 2009-01-20 US disclosed
WO-2008063501-A1 COMPOUNDS CRODA UNIQEMA, INC. (US) 2008-05-29 WO disclosed
EP-1643962-A1 SOLVATED NONIONIC SURFACTANTS AND FATTY ACIDS ICI Americas, Inc. (US) 2006-04-12 EP disclosed
US-20050233929-A1 Solvated nonionic surfactants and fatty acids ICI AMERICAS, INC. (US) 2005-10-20 US disclosed
US-20050026805-A1 Solvated nonionic surfactants and fatty acids ICI AMERICAS, INC. (US) 2005-02-03 US disclosed
WO-2005007242-A1 SOLVATED NONIONIC SURFACTANTS AND FATTY ACIDS ICI AMERICAS, INC. (US) 2005-01-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150265506-A1 Foam-Promoting Compounds SREBF1, SREBF2, EBP CA2 3718/4885GPR84 724/4885FFAR1 197/4885
US-20100080767-A1 COMPOUNDS SREBF1, SGMS1, EBP CA2 2650/4885GPR84 1245/4885FFAR1 255/4885
US-20050026805-A1 Solvated nonionic surfactants and fatty acids LIPC, PAOX, FASN CA2 1092/4885GPR84 491/4885FFAR1 19/4885
US-20140121141-A1 FRICTION MODIFIERS AND A METHOD OF MAKING THE SAME FLNA, ALK, FLNB CA2 3280/4885GPR84 656/4885FFAR1 328/4885
US-20090105106-A1 Solvated non-ionic surfactants and fatty acids PAOX, FFAR3, ELOVL3 CA2 795/4885GPR84 611/4885FFAR1 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.